Literature DB >> 14617188

amrA encodes a putative membrane protein necessary for maximal exponential phase expression of the Mga virulence regulon in Streptococcus pyogenes.

Deborah A Ribardo1, Kevin S McIver.   

Abstract

The transcriptional regulator Mga activates a regulon of virulence genes important for colonization and immune evasion in GAS. Using transposon mutagenesis of a serotype M6 group A streptococcus (GAS) reporter strain KSM148, we have identified an open reading frame (ORF) designated amrA that is required for maximal activation of the Mga regulon during exponential phase. A deletion in amrA, but not in the downstream transcriptionally linked ORF Spy0798, was able to reproduce the phenotype seen in the transposon mutants. Northern analysis for mga and emm transcripts, as well as Western analysis of Mga, confirmed a reduction in mga expression leading to a decrease in transcription of the Mga-regulated emm in the amrA deletion and transposon mutants. Furthermore, both the amrA deletion mutant and an original transposon mutant could be complemented using amrA expressed from a nisin-inducible expression system. As amrA is strongly conserved across the sequenced streptococcal M types, and inactivation of amrA in an M3 serotype also resulted in reduction of emm transcripts, the role of amrA does not appear to be serotype specific. Although the specific function of AmrA is unknown, its putative membrane localization and homology to transporters involved in cell wall synthesis suggest a link between growth and virulence gene expression in GAS.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14617188     DOI: 10.1046/j.1365-2958.2003.03726.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  9 in total

Review 1.  Functional genomics of gram-positive microorganisms.

Authors:  Marta Perego; James A Hoch; John F Barrett
Journal:  J Bacteriol       Date:  2004-02       Impact factor: 3.490

2.  Role of Streptococcus pyogenes two-component response regulators in the temporal control of Mga and the Mga-regulated virulence gene emm.

Authors:  Deborah A Ribardo; Thomas J Lambert; Kevin S McIver
Journal:  Infect Immun       Date:  2004-06       Impact factor: 3.441

3.  Identification of residues responsible for the defective virulence gene regulator Mga produced by a natural mutant of Streptococcus pyogenes.

Authors:  Cheryl M Vahling; Kevin S McIver
Journal:  J Bacteriol       Date:  2005-09       Impact factor: 3.490

4.  Genome-wide identification of genes required for fitness of group A Streptococcus in human blood.

Authors:  Yoann Le Breton; Pragnesh Mistry; Kayla M Valdes; Jeffrey Quigley; Nikhil Kumar; Hervé Tettelin; Kevin S McIver
Journal:  Infect Immun       Date:  2013-01-07       Impact factor: 3.441

5.  Domains required for transcriptional activation show conservation in the mga family of virulence gene regulators.

Authors:  Cheryl M Vahling; Kevin S McIver
Journal:  J Bacteriol       Date:  2006-02       Impact factor: 3.490

6.  First Streptococcus pyogenes signature-tagged mutagenesis screen identifies novel virulence determinants.

Authors:  Anne E Kizy; Melody N Neely
Journal:  Infect Immun       Date:  2009-02-17       Impact factor: 3.441

7.  The catabolite control protein CcpA binds to Pmga and influences expression of the virulence regulator Mga in the Group A streptococcus.

Authors:  Audry C Almengor; Traci L Kinkel; Stephanie J Day; Kevin S McIver
Journal:  J Bacteriol       Date:  2007-09-28       Impact factor: 3.490

8.  Transcriptional activation of sclA by Mga requires a distal binding site in Streptococcus pyogenes.

Authors:  Audry C Almengor; Kevin S McIver
Journal:  J Bacteriol       Date:  2004-12       Impact factor: 3.490

9.  Development of a novel selection/counter-selection system for chromosomal gene integrations and deletions in lactic acid bacteria.

Authors:  Winschau F Van Zyl; Leon M T Dicks; Shelly M Deane
Journal:  BMC Mol Biol       Date:  2019-03-29       Impact factor: 2.946

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.